Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Oxedrine Tartrate
2. Corvasymton
3. Simpadren
4. Sympathomim
5. 16589-24-5
6. Cardiodinamin
7. 9i99i5995j
8. Sympacor
9. Sympalept
10. Sympatizin
11. (2r,3r)-2,3-dihydroxybutanedioic Acid;4-[1-hydroxy-2-(methylamino)ethyl]phenol
12. Synephrinium Tartaricum
13. Sinefrina Tartrato
14. Sinefrina Tartrato [italian]
15. Einecs 200-642-3
16. P-hydroxyphenylmethylaminoaethanoltartrat
17. Oxyphenyl-methylamino-aethanolum Tartaricum
18. Unii-9i99i5995j
19. Einecs 240-647-8
20. Dacryoboraline (tn)
21. (+-)-1-(4-hydroxyphenyl)-2-methylaminoethanol Tartrate
22. (+-)-1-(4-idrossifenil)-2-metilaminoetanolo Tartrato [italian]
23. Bis(rs)-4-hydroxy-alpha-(methylaminomethyl)benzylalkohol)-(rr)-tartrat
24. Synephrine Tartrate (salt)
25. Oxedrine Hemitartrate
26. (+-)-1-(4-idrossifenil)-2-metilaminoetanolo Tartrato
27. Synephrine Tartrate [mi]
28. Synephrine Tartrate, Dl-
29. Dtxsid10985819
30. Oxedrine Tartrate [mart.]
31. Oxedrine Tartrate [who-dd]
32. Bcp13680
33. Mfcd00151120
34. 2,3-dihydroxybutanedioic Acid,4-[1-hydroxy-2-(methylamino)ethyl]phenol
35. Akos015909769
36. Benzyl Alcohol, P-hydroxy-alpha-((methylamino)methyl)-, Tartrate (2:1) (salt)
37. As-74464
38. D08308
39. D92240
40. Q27272589
41. (rs)-1-(4-hydroxyphenyl)-2-(methylamino)ethanol Tartrate
42. Bis((beta,4-dihydroxyphenethyl)methylammonium) (r-(r*,r*))-tartrate
43. (2r,3r)-2,3-dihydroxybutanedioic Acid; Bis(4-[1-hydroxy-2-(methylamino)ethyl]phenol)
44. 2,3-dihydroxybutanedioic Acid--4-[1-hydroxy-2-(methylamino)ethyl]phenol (1/2)
45. Benzenemethanol, 4-hydroxy-.alpha.-((methylamino)methyl)-, (2r,3r)-2,3-dihydroxybutanedioate (2:1)
46. Benzenemethanol, 4-hydroxy-alpha-((methylamino)methyl)-, (2r,3r)-2,3-dihydroxybutanedioate (2:1) (salt)
47. Benzenemethanol, 4-hydroxy-alpha-((methylamino)methyl)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (2:1) (salt)
Molecular Weight | 484.5 g/mol |
---|---|
Molecular Formula | C22H32N2O10 |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 9 |
Exact Mass | 484.20569522 g/mol |
Monoisotopic Mass | 484.20569522 g/mol |
Topological Polar Surface Area | 220 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 256 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
49
PharmaCompass offers a list of Cardiodinamin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cardiodinamin manufacturer or Cardiodinamin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cardiodinamin manufacturer or Cardiodinamin supplier.
PharmaCompass also assists you with knowing the Cardiodinamin API Price utilized in the formulation of products. Cardiodinamin API Price is not always fixed or binding as the Cardiodinamin Price is obtained through a variety of data sources. The Cardiodinamin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxedrin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxedrin, including repackagers and relabelers. The FDA regulates Oxedrin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxedrin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxedrin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxedrin supplier is an individual or a company that provides Oxedrin active pharmaceutical ingredient (API) or Oxedrin finished formulations upon request. The Oxedrin suppliers may include Oxedrin API manufacturers, exporters, distributors and traders.
click here to find a list of Oxedrin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxedrin written confirmation (Oxedrin WC) is an official document issued by a regulatory agency to a Oxedrin manufacturer, verifying that the manufacturing facility of a Oxedrin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxedrin APIs or Oxedrin finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxedrin WC (written confirmation) as part of the regulatory process.
click here to find a list of Oxedrin suppliers with Written Confirmation (WC) on PharmaCompass.
Oxedrin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxedrin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxedrin GMP manufacturer or Oxedrin GMP API supplier for your needs.
A Oxedrin CoA (Certificate of Analysis) is a formal document that attests to Oxedrin's compliance with Oxedrin specifications and serves as a tool for batch-level quality control.
Oxedrin CoA mostly includes findings from lab analyses of a specific batch. For each Oxedrin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxedrin may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxedrin EP), Oxedrin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxedrin USP).